Research ArticleNuclear Oncology
False-Positive FDG-PET Imaging of the Thymus of a Child with Hodgkin's Disease
Mark E. Weinblatt, Italo Zanzi, Abdelfathie Belakhlef, Barry Babchyck and Joseph Kochen
Journal of Nuclear Medicine June 1997, 38 (6) 888-890;
Mark E. Weinblatt
Italo Zanzi
Abdelfathie Belakhlef
Barry Babchyck
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
False-Positive FDG-PET Imaging of the Thymus of a Child with Hodgkin's Disease
Mark E. Weinblatt, Italo Zanzi, Abdelfathie Belakhlef, Barry Babchyck, Joseph Kochen
Journal of Nuclear Medicine Jun 1997, 38 (6) 888-890;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma
- 18F-FDG PET Evaluation of the Response to Therapy for Lymphoma and for Breast, Lung, and Colorectal Carcinoma
- Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
- FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography andCT
- Whole-Body Positron Emission Tomography Using 18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin's Disease and Non-Hodgkin's Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging